| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 80 | 2021 |
| Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review Á Rodríguez-Villodres, C Martín-Gandul, G Peñalva, AB Guisado-Gil, ... Antibiotics 10 (6), 680, 2021 | 67 | 2021 |
| The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant MG López, Á Chiner-Oms, D García de Viedma, P Ruiz-Rodriguez, ... Nature genetics 53 (10), 1405-1414, 2021 | 64 | 2021 |
| Antibacterial activity of colloidal silver against gram-negative and gram-positive bacteria A Vila Domínguez, R Ayerbe Algaba, A Miró Canturri, ... Antibiotics 9 (1), 36, 2020 | 32 | 2020 |
| Are antimicrobial stewardship interventions effective and safe in long-term care facilities? A systematic review and meta-analysis JC Crespo-Rivas, AB Guisado-Gil, G Peñalva, Á Rodríguez-Villodres, ... Clinical Microbiology and Infection 27 (10), 1431-1438, 2021 | 30 | 2021 |
| Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli Á Rodríguez-Villodres, ML Gil-Marqués, R Álvarez-Marín, RA Bonnin, ... Journal of Antimicrobial Chemotherapy 75 (1), 77-85, 2020 | 27 | 2020 |
| Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis MÀ Sastre-Femenia, A Fernández-Muñoz, MA Gomis-Font, B Taltavull, ... The lancet regional health–Europe 34, 2023 | 17 | 2023 |
| Clinical and ecological impact of an Educational Program to optimize antibiotic treatments in nursing homes (PROA-SENIOR): a cluster, Randomized, controlled trial and … G Peñalva, JC Crespo-Rivas, AB Guisado-Gil, Á Rodríguez-Villodres, ... Clinical Infectious Diseases 76 (5), 824-832, 2023 | 12 | 2023 |
| High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus JMO de la Rosa, MA Fernández, Á Rodríguez-Villodres, ... International Journal of Antimicrobial Agents 61 (6), 106795, 2023 | 9 | 2023 |
| Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to β-lactams/β-lactamase inhibitors in clinical isolates of escherichia coli Á Rodríguez-Villodres, A Gutiérrez Linares, L Gálvez-Benitez, J Pachón, ... Microbiology Spectrum 9 (2), e00801-21, 2021 | 9 | 2021 |
| REIPI-SEIMC COVID-19 group and COVID@ HULP groups. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID … B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... Lancet Infect Dis 21 (6), 783-792, 2021 | 9 | 2021 |
| A selective culture medium for screening linezolid-resistant gram-positive bacteria P Nordmann, A Rodríguez-Villodres, L Poirel Diagnostic microbiology and infectious disease 95 (1), 1-4, 2019 | 8 | 2019 |
| Effect of subinhibitory concentrations of ampicillin on Listeria monocytogenes Á Rodríguez-Villodres, JA Lepe, J Blázquez, J Aznar Enfermedades Infecciosas y Microbiología Clínica 38 (2), 72-75, 2020 | 5 | 2020 |
| Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections Á Rodríguez-Villodres, RA Bonnin, JM Ortiz de la Rosa, R Álvarez-Marín, ... Journal of Clinical Medicine 8 (12), 2118, 2019 | 5 | 2019 |
| In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes JA Lepe, Á Rodríguez-Villodres, G Martín-Gutiérrez, R Luque, J Aznar Revista Española de Quimioterapia 32 (5), 465, 2019 | 5 | 2019 |
| Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131 Á Rodríguez-Villodres, JM Ortiz de la Rosa, R Álvarez-Marín, J Pachón, ... Antimicrobial Agents and Chemotherapy 62 (1), 10.1128/aac. 01923-17, 2018 | 5 | 2018 |
| Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to β-lactams/β-lactamase inhibitors in clinical isolates of escherichia coli … Á Rodríguez-Villodres, A Gutiérrez Linares, L Gálvez-Benitez, J Pachón, ... Spectrum, 00801-21, 0 | 5 | |
| Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022 M Boattini, G Bianco, LI Llorente, LA Acero, D Nunes, M Seruca, ... International Journal of Antimicrobial Agents 63 (5), 107115, 2024 | 4 | 2024 |
| Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test A Rodríguez Villodres, L Gálvez Benítez, MJ Arroyo, G Méndez, ... Emerging Microbes & Infections 11 (1), 2034-2044, 2022 | 4 | 2022 |
| Enfermedad recurrente por Clostridium difficile ribotipo 027 Á Rodríguez-Villodres, J Praena, MR Vidal-Acuña, J Aznar Enferm. infecc. microbiol. clín.(Ed. impr.), 461-462, 2016 | 3 | 2016 |
